Cargando…
Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives
Primary biliary cholangitis (PBC) is a cholestatic autoimmune liver disease characterized by the gradual destruction of small intrahepatic bile ducts that eventually leads to liver cirrhosis, failure, and even carcinoma. The treatment options for PBC are limited, and the main treatment choices are t...
Autores principales: | Yang, Yanlei, Zhao, Robert Chunhua, Zhang, Fengchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339990/ https://www.ncbi.nlm.nih.gov/pubmed/35923849 http://dx.doi.org/10.3389/fcell.2022.933565 |
Ejemplares similares
-
Long Non-coding RNA Regulation of Mesenchymal Stem Cell Homeostasis and Differentiation: Advances, Challenges, and Perspectives
por: Yang, Yanlei, et al.
Publicado: (2021) -
Animal models of primary biliary cholangitis: status and challenges
por: Wang, Xu, et al.
Publicado: (2023) -
Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization
por: Najar, Mehdi, et al.
Publicado: (2022) -
Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges
por: Wang, Shihua H., et al.
Publicado: (2021) -
Therapeutic Potential of Wharton’s Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges
por: Kamal, Mohamed M., et al.
Publicado: (2020)